Edition:
India

ConvaTec Group PLC (CTEC.L)

CTEC.L on London Stock Exchange

217.70GBp
2:41pm IST
Change (% chg)

2.10 (+0.97%)
Prev Close
215.60
Open
213.80
Day's High
217.70
Day's Low
211.90
Volume
289,491
Avg. Vol
6,340,666
52-wk High
340.30
52-wk Low
181.40

Latest Key Developments (Source: Significant Developments)

UBS Says Nordic Capital Sold 143.2 Mln Shares In Convatec
Thursday, 3 May 2018 

May 3 (Reuters) - UBS Ltd: :RESULT OF PLACING OF ORDINARY SHARES IN CONVATEC GROUP PLC.NORDIC CAPITAL IT SOLD 143.2 MILLION ORDINARY SHARES IN CONVATEC GROUP PLC.PLACING BY WAY OF AN ACCELERATED BOOKBUILD PROCESS AT A PRICE OF 220 PENCE PER ORDINARY SHARE, RAISING GROSS PROCEEDS OF £315 MILLION.CONVATEC WILL NOT RECEIVE ANY PROCEEDS FROM PLACING.UBS LIMITED ACTED AS SOLE BOOKRUNNER IN CONNECTION WITH PLACING.  Full Article

Convatec Group Q1 Group Revenue $458.2 Mln, Up 3.7 Pct
Wednesday, 2 May 2018 

May 2 (Reuters) - ConvaTec Group PLC ::Q1 GROUP REVENUE OF $458.2 MILLION GREW 3.7%.2018 FINANCIAL GUIDANCE RE-AFFIRMED: ORGANIC REVENUE GROWTH 2.5% TO 3.0%; ADJUSTED EBIT MARGIN 24% TO 25%.Q1 OSTOMY CARE REVENUE DECLINED 2.5%.Q1 ADVANCED WOUND CARE REVENUE GREW 2.2%.  Full Article

Convatec reports Q3 revenue of $445.5 mln, up 6.8 pct
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Convatec Group Plc ::IN Q3, GROUP REVENUE WAS $445.5 MILLION, REFLECTING 6.8 PCT REPORTED GROWTH ON SAME PERIOD IN 2016​.PERFORMANCE IN Q3 SEVERELY IMPACTED BY SUPPLY ISSUES IN BOTH ADVANCED WOUND AND OSTOMY CARE.‍GROUP NOW ANTICIPATE FULL YEAR ORGANIC REVENUE GROWTH WILL BE BETWEEN 1% AND 2%​.‍SUPPLY ISSUES ARE EXPECTED TO RESULT IN LOSS OF 40 BPS OF MARGIN BENEFIT ACHIEVED AS A RESULT OF MIP PROGRAMME IN FIRST HALF OF YEAR​.  Full Article

BRIEF-UBS Says Nordic Capital Sold 143.2 Mln Shares In Convatec

* NORDIC CAPITAL IT SOLD 143.2 MILLION ORDINARY SHARES IN CONVATEC GROUP PLC